Genmab A/S (GMAB)
29.29
+0.39
(+1.35%)
USD |
NASDAQ |
Feb 20, 16:00
29.30
+0.01
(+0.03%)
Pre-Market: 20:00
Genmab Market Cap : 18.04B for Feb. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AbbVie, Inc. | 397.33B |
| Krystal Biotech, Inc. | 7.592B |
| Novo Nordisk A/S | 210.86B |
| Ascendis Pharma A/S | 13.81B |
| Zealand Pharma A/S | 4.247B |
Market Cap Related Metrics
| PE Ratio | 18.92 |
| PS Ratio | 5.005 |
| Price to Book Value | 3.086 |
| Price to Free Cash Flow | 16.44 |
| Price | 29.29 |
| Earnings Yield | 5.29% |
| Operating PE Ratio | 14.89 |
| Normalized PE Ratio | 16.83 |